Turtle Creek Wealth Advisors LLC Makes New $2.95 Million Investment in The Cigna Group (NYSE:CI)

Turtle Creek Wealth Advisors LLC acquired a new position in The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 9,834 shares of the health services provider's stock, valued at approximately $2,945,000.

Several other institutional investors also recently modified their holdings of the stock. Ellsworth Advisors LLC bought a new position in The Cigna Group during the fourth quarter valued at approximately $4,377,000. Accurate Wealth Management LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $2,244,000. Dfpg Investments LLC boosted its stake in shares of The Cigna Group by 92.0% during the fourth quarter. Dfpg Investments LLC now owns 7,160 shares of the health services provider's stock valued at $2,174,000 after purchasing an additional 3,430 shares during the period. Asset Management One Co. Ltd. boosted its stake in shares of The Cigna Group by 3.3% during the fourth quarter. Asset Management One Co. Ltd. now owns 121,836 shares of the health services provider's stock valued at $36,478,000 after purchasing an additional 3,925 shares during the period. Finally, Brandywine Global Investment Management LLC boosted its stake in shares of The Cigna Group by 1.5% during the third quarter. Brandywine Global Investment Management LLC now owns 444,817 shares of the health services provider's stock valued at $127,249,000 after purchasing an additional 6,365 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the sale, the chief executive officer now directly owns 329,321 shares in the company, valued at approximately $110,394,985.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business's stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares in the company, valued at approximately $694,668.96. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David Cordani sold 38,065 shares of the business's stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the sale, the chief executive officer now owns 329,321 shares of the company's stock, valued at $110,394,985.62. The disclosure for this sale can be found here. In the last ninety days, insiders sold 114,144 shares of company stock worth $39,296,330. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Stock Down 0.1 %

Shares of NYSE:CI traded down $0.49 on Tuesday, hitting $357.49. 1,129,195 shares of the company traded hands, compared to its average volume of 1,628,400. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The stock has a 50 day simple moving average of $342.75 and a 200-day simple moving average of $311.92. The company has a market cap of $104.52 billion, a PE ratio of 20.59, a PEG ratio of 1.11 and a beta of 0.56.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm had revenue of $51.15 billion during the quarter, compared to the consensus estimate of $48.91 billion. During the same period last year, the company earned $4.96 earnings per share. The company's revenue was up 11.8% on a year-over-year basis. As a group, research analysts expect that The Cigna Group will post 28.36 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 21st. Investors of record on Wednesday, March 6th were issued a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.57%. This is an increase from The Cigna Group's previous quarterly dividend of $1.23. The ex-dividend date was Tuesday, March 5th. The Cigna Group's dividend payout ratio (DPR) is presently 32.20%.

Analyst Ratings Changes

CI has been the subject of a number of research analyst reports. Morgan Stanley reaffirmed an "overweight" rating and issued a $392.00 price target (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Sanford C. Bernstein raised The Cigna Group from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $330.00 to $372.00 in a research note on Thursday, January 4th. Mizuho raised their price target on The Cigna Group from $360.00 to $370.00 and gave the stock a "buy" rating in a research note on Monday, February 5th. Royal Bank of Canada raised The Cigna Group from a "sector perform" rating to an "outperform" rating and raised their price objective for the company from $327.00 to $354.00 in a research report on Monday, February 5th. Finally, StockNews.com raised The Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Thursday, March 14th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, The Cigna Group currently has a consensus rating of "Buy" and a consensus price target of $361.29.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.